JAK2-Unmutated Erythrocytosis in Chronic Phase Myeloid Leukemia (CP-CML) During Tyrosine Kinase Inhibitor (TKI) Treatment

Olga Kulemina, Julia Yakovleva,Natalia Lazorko,Tamara Chitanava,Nadia Siordia, Nadezhda Shnalieva, Elena Tochenaya, Polina Mateikovich,Elza Lomaia

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

Cited 0|Views3

No score

Key words

CML, erythrocytosis, tyrosine kinase inhibitors, case

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined